Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. (APLS) is a publicly traded company in the Unknown sector. Across all available filings, 32 corporate insiders have executed 890 transactions totaling $248.1M, demonstrating a bearish sentiment with -$74.0M in net insider flow. The most recent transaction on Feb 3, 2026 involved a transaction of 8,840 shares valued at $0.
APLS Insider Activity Summary
Who Is Buying APLS Stock?
No significant insider buying has been recorded for APLS in the recent period.
Who Is Selling APLS Stock?
No significant insider selling has been recorded for APLS in the recent period.
Is Apellis Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for APLS is bearish with an Insider Alignment Score of 35/100 and a net flow of -$74.0M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
APLS Frequently Asked Questions
Understanding APLS Insider Activity
Insider trading at Apellis Pharmaceuticals, Inc. (APLS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 32 insiders are actively trading APLS stock, having executed 890 transactions in the past 90 days. The most active insider is Cedric Francois (Executive), who has made 124 transactions totaling $55.9M.
Related Tools
Track Apellis Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at APLS file new Form 4 transactions